0001062993-12-001712.txt : 20120514 0001062993-12-001712.hdr.sgml : 20120514 20120514131107 ACCESSION NUMBER: 0001062993-12-001712 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120510 FILED AS OF DATE: 20120514 DATE AS OF CHANGE: 20120514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gao David CENTRAL INDEX KEY: 0001331795 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34566 FILM NUMBER: 12837629 MAIL ADDRESS: STREET 1: C/ BEIJING MED-PHARM CORPORATION STREET 2: 600 W. GERMANTOWN PIKE, SUITE 400 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: China Biologic Products, Inc. CENTRAL INDEX KEY: 0001369868 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 752308816 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: NO.14 EAST HUSHAN ROAD CITY: TAI'AN CITY, SHANDONG STATE: F4 ZIP: 271000 BUSINESS PHONE: 86-538-620-3897 MAIL ADDRESS: STREET 1: NO.14 EAST HUSHAN ROAD CITY: TAI'AN CITY, SHANDONG STATE: F4 ZIP: 271000 FORMER COMPANY: FORMER CONFORMED NAME: GRC Holdings, Inc. DATE OF NAME CHANGE: 20060721 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0305 4 2012-05-10 0001369868 China Biologic Products, Inc. CBPO 0001331795 Gao David 18TH FLOOR, JIALONG INTERNATIONAL BUILDING, 19 CHAOYANG PARK ROAD BEIJING F4 100125 CHINA 1 1 0 0 Chief Executive Officer Common Stock 2012-05-11 4 P 0 4290 9.50 A 4290 I By Spouse Stock Option (right to buy) 9.23 2012-05-10 4 A 0 300000 0 A 2022-05-11 Common Stock 300000 320000 D Granted pursuant to a stock option agreement dated May 11, 2012 between the Company and Mr. Gao (the "Stock Option Agreement"). Pursuant to the Stock Option Agreement, the stock options will vest in twelve equal portions on a quarterly basis over a 3-year period, with the first portion vesting on August 11, 2012, provided that Mr. Gao is employed by the Company on each vesting date. As of May 14, 2012, Mr. Gao is the holder of stock options to purchase an aggregate of 320,000 shares of common stock of the Issuer, among which the stock options to purchase 20,000 shares were granted pursuant to a stock option agreement dated as of October 6, 2011 between the Company and Mr. Gao. /s/ David (Xiaoying) Gao 2012-05-14